Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn
With most interest we read the contribution made by Fauconnier on phage therapy regulation [...]
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/11/9/771 |
_version_ | 1818974146431811584 |
---|---|
author | Eric Pelfrene Zigmars Sebris Marco Cavaleri |
author_facet | Eric Pelfrene Zigmars Sebris Marco Cavaleri |
author_sort | Eric Pelfrene |
collection | DOAJ |
description | With most interest we read the contribution made by Fauconnier on phage therapy regulation [...] |
first_indexed | 2024-12-20T15:35:25Z |
format | Article |
id | doaj.art-557c702b8d1d44f580a0a302df6587cf |
institution | Directory Open Access Journal |
issn | 1999-4915 |
language | English |
last_indexed | 2024-12-20T15:35:25Z |
publishDate | 2019-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Viruses |
spelling | doaj.art-557c702b8d1d44f580a0a302df6587cf2022-12-21T19:35:27ZengMDPI AGViruses1999-49152019-08-0111977110.3390/v11090771v11090771Comment on Fauconnier, A. Phage Therapy Regulation: From Night to DawnEric Pelfrene0Zigmars Sebris1Marco Cavaleri2Office of Anti-Infectives and Vaccines, Human Medicines Evaluation Division, European Medicines Agency, 1083 HS Amsterdam, The NetherlandsRegulatory Affairs Office, Human Medicines Evaluation Division, European Medicines Agency, 1083 HS Amsterdam, The NetherlandsOffice of Anti-Infectives and Vaccines, Human Medicines Evaluation Division, European Medicines Agency, 1083 HS Amsterdam, The NetherlandsWith most interest we read the contribution made by Fauconnier on phage therapy regulation [...]https://www.mdpi.com/1999-4915/11/9/771antimicrobial resistancebacteriophagepersonalised medicinesphage therapypharmaceutical legislationregulatory framework |
spellingShingle | Eric Pelfrene Zigmars Sebris Marco Cavaleri Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn Viruses antimicrobial resistance bacteriophage personalised medicines phage therapy pharmaceutical legislation regulatory framework |
title | Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn |
title_full | Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn |
title_fullStr | Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn |
title_full_unstemmed | Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn |
title_short | Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn |
title_sort | comment on fauconnier a phage therapy regulation from night to dawn |
topic | antimicrobial resistance bacteriophage personalised medicines phage therapy pharmaceutical legislation regulatory framework |
url | https://www.mdpi.com/1999-4915/11/9/771 |
work_keys_str_mv | AT ericpelfrene commentonfauconnieraphagetherapyregulationfromnighttodawn AT zigmarssebris commentonfauconnieraphagetherapyregulationfromnighttodawn AT marcocavaleri commentonfauconnieraphagetherapyregulationfromnighttodawn |